ArriVent BioPharma Stock (NASDAQ: AVBP) stock price, news, charts, stock research, profile.
You can purchase shares of ArriVent BioPharma (NASDAQ:AVBP) through any online brokerage.
Other companies in ArriVent BioPharma’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), Replimune Group (NASDAQ:REPL) and Prothena Corp (NASDAQ:PRTA).
ArriVent BioPharma has a consensus price target of $36.80.
The stock price for ArriVent BioPharma (NASDAQ: AVBP) is $23.79 last updated October 1, 2024 at 4:00 PM EDT.
There are no upcoming dividends for ArriVent BioPharma.
ArriVent BioPharma’s Q3 earnings are confirmed for Saturday, November 2, 2024.
There is no upcoming split for ArriVent BioPharma.
ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.